Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Inhibiteur de la phosphodiestérase 5")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 821

  • Page / 33
Export

Selection :

  • and

Insuffisance érectile : Prescrire un inhibiteur de la phosphodiestérase 5 en première intentionSTAERMAN, Frédéric.Concours médical (Paris). 2009, Vol 131, Num 7, pp 221-224, issn 0010-5309, 4 p.Article

Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risksJACKSON, G; ARVER, S; BANKS, I et al.International journal of clinical practice (Esher). 2010, Vol 64, Num 4, pp 497-504, issn 1368-5031, 8 p.Article

Isolation and identification of thiohomosildenafil and thiosildenafil in health supplementsPENG ZOU; PEILING HOU; OH, Sharon Sze-Yin et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 47, Num 2, pp 279-284, issn 0731-7085, 6 p.Article

Safety of Prescribing PDE-5 Inhibitors via e-Medicine vs Traditional MedicineMUNGER, Mark A; STODDARD, Gregory J; WENNER, Allen R et al.Mayo Clinic proceedings. 2008, Vol 83, Num 8, pp 890-896, issn 0025-6196, 7 p.Article

Phosphodiesterase Type 5 Inhibitor Use and Hearing ImpairmentMCGWIN, Gerald.Archives of otolaryngology, head & neck surgery. 2010, Vol 136, Num 5, pp 488-492, issn 0886-4470, 5 p.Article

Role of Growth Factors in Improved Skin Flap Viability Caused by Phosphodiesterase-5 InhibitorBANDERA, Bradley C; PHAM, Thach; HILL-PRYOR, Crystal et al.The American surgeon. 2010, Vol 76, Num 6, pp 614-617, issn 0003-1348, 4 p.Article

Is phosphodiesterase type 5 inhibitor use associated with condom breakage? CommentaryCROSBY, R; YARBER, W. L; SANDERS, S. A et al.Sexually transmitted infections. 2009, Vol 85, Num 5, pp 404-406, issn 1368-4973, 3 p.Article

Isolation and structure elucidation of an interaction product of aminotadalafil found in an illegal health food productHÄBERLI, Adrian; GIRARD, Philippe; LOW, Min-Yong et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 53, Num 1, pp 24-28, issn 0731-7085, 5 p.Article

Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial HypertensionARCHER, Stephen L; MICHELAKIS, Evangelos D.The New England journal of medicine. 2009, Vol 361, Num 19, pp 1864-1871, issn 0028-4793, 8 p.Article

Classification trees based on infrared spectroscopic data to discriminate between genuine and counterfeit medicinesDECONINCK, E; SACRE, P. Y; COOMANS, D et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 57, Num C, pp 68-75, issn 0731-7085, 8 p.Article

The Successful Use of Phosphodiesterase Type 5 Inhibitors to Treat the Syndrome of Cor Pulmonale and Prerenal Azotemia with Diuresis of Anasarca (CorPRADA)BEREZ, Paul Bruce.Southern medical journal (Birmingham, Ala. Print). 2010, Vol 103, Num 2, pp 116-120, issn 0038-4348, 5 p.Article

Effect of phosphodiesterase-5 inhibitor on hearingOKUYUCU, S; GUVEN, O. E; AKOGLU, E et al.Journal of laryngology and otology. 2009, Vol 123, Num 7, pp 718-722, issn 0022-2151, 5 p.Article

Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysisTSERTSVADZE, Alexander; FINK, Howard A; FOX, Steven et al.Annals of internal medicine. 2009, Vol 151, Num 9, pp 650-661, issn 0003-4819, 12 p.Article

Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunctionSADOVSKY, R; BROCK, G. B; GUTKIN, S. W et al.International journal of clinical practice (Esher). 2009, Vol 63, Num 8, pp 1214-1230, issn 1368-5031, 17 p.Article

Phosphodiesterase 5 inhibitors : Drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles : Phosphodiesterase 5 inhibitors : pharmacology and therapeutic perspectivesSUPURAN, Claudiu T; MASTROLORENZO, Antonio; BARBARO, Giuseppe et al.Current pharmaceutical design. 2006, Vol 12, Num 27, pp 3459-3465, issn 1381-6128, 7 p.Article

Lifestyle and metabolic approaches to maximizing erectile and vascular healthMELDRUM, D. R; GAMBONE, J. C; MORRIS, M. A et al.International journal of impotence research. 2012, Vol 24, Num 2, pp 61-68, issn 0955-9930, 8 p.Article

Effects of phosphodiesterase type 5 inhibitors on endothelial function and cardiovascular autonomic nerve function in menSTIRBAN, Alin; TAMLER, Ronald; ANDREI VERESIU, Loan et al.Journal of men's health (Print). 2011, Vol 8, Num 2, pp 109-118, issn 1875-6867, 10 p.Article

Phosphodiesterase-5 inhibitors and rosacea : report of 10 casesIOANNIDES, D; LAZARIDOU, E; APALLA, Z et al.British journal of dermatology (1951). 2009, Vol 160, Num 3, pp 719-720, issn 0007-0963, 2 p.Article

How to optimise treatment of erectile dysfunction above and beyond the beneficial effects of a phosphodiesterase type 5 inhibitorGOOREN, Louis.Journal of men's health. 2008, Vol 5, Num 2, pp 163-170, 8 p.Article

Structural elucidation of a PDE-5 inhibitor detected as an adulterant in a health supplementXIAOWEI GE; LOW, Min-Yong; PENG ZOU et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 4, pp 1070-1075, issn 0731-7085, 6 p.Article

Erectile Dysfunction and Cardiovascular Disease : Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both ConditionsNEHRA, Ajay.Mayo Clinic proceedings. 2009, Vol 84, Num 2, pp 139-148, issn 0025-6196, 10 p.Article

Alprostadil for the treatment of impotenceHANCHANALE, Vishwanath; EARDLEY, Ian.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 3, pp 421-428, issn 1465-6566, 8 p.Article

Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation?AVERSA, A; FRANCOMANO, D; BRUZZICHES, R et al.International journal of impotence research. 2011, Vol 23, Num 1, pp 17-23, issn 0955-9930, 7 p.Article

Erectile dysfunction and heart failure : the role of phosphodiesterase type 5 inhibitorsAL-AMERI, H; KLONER, R. A.International journal of impotence research. 2009, Vol 21, Num 3, pp 149-157, issn 0955-9930, 9 p.Article

Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction : results from the Erectile Dysfunction Observational StudyHATZICHRISTOU, D; HARE, J. M; MARTIN-MORALES, A et al.International journal of clinical practice (Esher). 2007, Vol 61, Num 11, pp 1850-1862, issn 1368-5031, 13 p.Article

  • Page / 33